# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

B-Cell Lymphomas

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 2111-2120 of 2220 results.
A Study of Induction and Maintenance Treatment With MabThera (Rituximab) in Patients With Indolent B-Cell Nonfollicular Lymphomas
Status: Completed
Last Changed: Aug 01, 2017
First Received: Jun 30, 2010
Disease(s): Non-Hodgkin's Lymphoma
Intervention(s): rituximab
Locations: Ospedale Civile Dello Spirito Santo; Divisione Di Ematologia, Pescara, Abruzzo, Italy
Ospedale Civile; Divisione Di Oncologia, Pescara, Abruzzo, Italy
Ospedale Oncologico Regionale; U.O. Oncologia Medica Ed Ematologia, Rionero in Vulture, Basilicata, Italy
Ospedale Riuniti; Divisione Di Ematologia, Reggio Calabria, Calabria, Italy
A.O.U. Policlinico di Modena-Dipartimento di Medicina Diagnostica, Clinica e di Sanità pubblica, Modena, Emilia-Romagna, Italy
... and 11 other locations.
Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Status: Terminated
Last Changed: Feb 17, 2020
First Received: Mar 17, 2016
Disease(s): Solid Tumors
Intervention(s): INCB057643, INCB057643, Gemcitabine, Paclitaxel, Rucaparib, Abiraterone, Ruxolitinib, Azacitidine
Locations: University of Alabama, Birmingham, Alabama, United States
University of California, La Jolla, California, United States
Sarah Cannon Research Institute at Health One, Denver, Colorado, United States
Yale University, New Haven, Connecticut, United States
Sylvester Comprehensive Cancer Center, Miami, Florida, United States
... and 14 other locations.
Alvespimycin Hydrochloride in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia
Status: Terminated
Last Changed: Nov 04, 2015
First Received: May 19, 2010
Disease(s): B-cell Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia
Intervention(s): alvespimycin hydrochloride, diagnostic laboratory biomarker analysis, pharmacogenomic studies, pharmacological study
Locations: Ohio State University Medical Center, Columbus, Ohio, United States
Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant
Status: Terminated
Last Changed: May 14, 2013
First Received: Aug 12, 2009
Disease(s): Cancer
Intervention(s): polymorphism analysis, laboratory biomarker analysis
Locations: Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville, Tennessee, United States
Vanderbilt-Ingram Cancer Center at Franklin, Nashville, Tennessee, United States
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
Pharmacokinetics (PK), Pharmacodynamics (PD), Safety, Tolerability of Multiple Dose Regimens of MT-3724 for the Treatment of Patients With Relapsed Chronic B-cell Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Withdrawn
Last Changed: Mar 02, 2016
First Received: Sep 22, 2015
Disease(s): Chronic B-cell Lymphocytic Leukemia, Small Lymphocytic Leukemia
Intervention(s): MT-3724, MT-3724, MT-3724, MT-3724, MT-3724
A Phase 1b Study Evaluating GS-9820 in Subjects With Lymphoid Malignancies
Status: Completed
Last Changed: May 17, 2016
First Received: Oct 12, 2012
Disease(s): Lymphoid Malignancies
Intervention(s): GS-9820
Locations: VU Medical Center (VUmc), Amsterdam, Netherlands
Academic Medical Center, Amsterdam, Netherlands
St. Antonius Hospital, Nieuwegein, Netherlands
Erasmus MC - Daniel den Hoed Cancer Center, Rotterdam, Netherlands
A Study of Obinutuzumab in Combination With Chemotherapy in Participants With CD20+ B-Cell Follicular Non-Hodgkin's Lymphoma
Status: Completed
Last Changed: Nov 04, 2016
First Received: Jan 19, 2009
Disease(s): Non-Hodgkin's Lymphoma
Intervention(s): Bendamustine, Cyclophosphamide, Doxorubicin, Fludarabine, Obinutuzumab, Prednisone, Vincristine
Locations: Kogarah, New South Wales, Australia
Sydney, New South Wales, Australia
Greenslopes, Queensland, Australia
Woolloongabba, Queensland, Australia
Kurralta Park, South Australia, Australia
... and 30 other locations.
A Trial to Investigate the Efficacy of Bendamustine in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Refractory to Rituximab.
Status: Terminated
Last Changed: Sep 04, 2018
First Received: Feb 03, 2011
Disease(s): Indolent B-cell NHL
Intervention(s): Bendamustine IV, Treatment of Physicians Choice
Locations: Princess Alexandra Hospital, Brisbane, Queensland, Australia
Royal Adelaide Hospital, Adelaide, Australia
Dr Ludmila Demitrovicova, Bratislava, Slovakia
A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin Lymphoma
Status: Completed
Last Changed: May 06, 2020
First Received: Nov 21, 2013
Disease(s): Hodgkin Lymphoma
Intervention(s): Brentuximab vedotin
Locations: Praha, Prague, Czechia
Brno, Czechia
Heidelberg, Baden Wuerttemberg, Germany
Koeln, Germany
Georgetown, Penang, Malaysia
... and 14 other locations.
Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haploidentical Related Hematopoietic
Status: Recruiting
Last Changed: Jun 18, 2020
First Received: Dec 09, 2016
Disease(s): Hematologic Malignancies
Intervention(s): Haplo HCT <55 years old, Haplo HCT ≥55 years old, GVHD Prophylaxis, Haplo HCT ≥55 and < 65 years old, Haplo HCT ≥65 and ≤75 years old
Locations: Masonic Cancer Center at University of Minnesota, Minneapolis, Minnesota, United States